Abbott/Premier
This article was originally published in The Gray Sheet
Executive Summary
Seven-year, multi-billion dollar corporate partnership effective in July extends existing agreements between Premier and Abbott and adds new relationships in patient-controlled analgesia, anesthesia trays, hematology, injectable drugs and pharmaceuticals